Literature DB >> 28902570

Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy.

Lisa Rosenbaum1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28902570     DOI： 10.1056/NEJMp1711886

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  33 in total

Review 1.  Mechanisms of resistance to CAR T cell therapy.

Authors:  Nirali N Shah; Terry J Fry
Journal:  Nat Rev Clin Oncol       Date:  2019-06       Impact factor: 66.675

Review 2.  The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19.

Authors:  Peter Braendstrup; Bruce L Levine; Marco Ruella
Journal:  Cytotherapy       Date:  2020-02-01       Impact factor: 5.414

3.  Seek and You Will Not Find: Ending the Hunt for Replication-Competent Retroviruses during Human Gene Therapy.

Authors:  Helen E Heslop; Malcolm K Brenner
Journal:  Mol Ther       Date:  2017-12-20       Impact factor: 11.454

Review 4.  Driving the CAR to the Bone Marrow Transplant Program.

Authors:  Hema Dave; Lauren Jerkins; Patrick J Hanley; Catherine M Bollard; David Jacobsohn
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

Review 5.  Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives.

Authors:  Sarju Ganatra; Joseph R Carver; Salim S Hayek; Bonnie Ky; Monika J Leja; Daniel J Lenihan; Carrie Lenneman; Negaresh Mousavi; Jae H Park; Miguel Angel Perales; Thomas D Ryan; Marielle Scherrer-Crosbie; Richard M Steingart; Eric H Yang; Vlad Zaha; Ana Barac; Jennifer E Liu
Journal:  J Am Coll Cardiol       Date:  2019-12-24       Impact factor: 24.094

Review 6.  Nanomedicine and macroscale materials in immuno-oncology.

Authors:  Qingxue Sun; Matthias Barz; Bruno G De Geest; Mustafa Diken; Wim E Hennink; Fabian Kiessling; Twan Lammers; Yang Shi
Journal:  Chem Soc Rev       Date:  2019-01-02       Impact factor: 54.564

Review 7.  CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease.

Authors:  Katherine C Pehlivan; Brynn B Duncan; Daniel W Lee
Journal:  Curr Hematol Malig Rep       Date:  2018-10       Impact factor: 3.952

8.  Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo.

Authors:  Xingkang He; Xin Yin; Jing Wu; Stina L Wickström; Yanhong Duo; Qiqiao Du; Shuhang Qin; Shuzhong Yao; Xu Jing; Kayoko Hosaka; Jieyu Wu; Lasse D Jensen; Andreas Lundqvist; Alexander I Salter; Lars Bräutigam; Wei Tao; Yuguo Chen; Rolf Kiessling; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-28       Impact factor: 11.205

Review 9.  Nongenetic Bioconjugation Strategies for Modifying Cell Membranes and Membrane Proteins: A Review.

Authors:  Shambojit Roy; Jennifer N Cha; Andrew P Goodwin
Journal:  Bioconjug Chem       Date:  2020-11-04       Impact factor: 4.774

Review 10.  Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells.

Authors:  Haneen Shalabi; Juliane Gust; Agne Taraseviciute; Pamela L Wolters; Allison B Leahy; Carlos Sandi; Theodore W Laetsch; Lori Wiener; Rebecca A Gardner; Veronique Nussenblatt; Joshua A Hill; Kevin J Curran; Timothy S Olson; Colleen Annesley; Hao-Wei Wang; Javed Khan; Marcelo C Pasquini; Christine N Duncan; Stephan A Grupp; Michael A Pulsipher; Nirali N Shah
Journal:  Nat Rev Clin Oncol       Date:  2021-01-25       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.